Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „lurasidone“
Suchtreffer
Begriffe & Kennungen
Darunavir Viatris (previously Darunavir Mylan) · 4.3 · 44 - cisapride - dapoxetine - domperidone - naloxegol - lurasidone, pimozide, quetiapine, sertindole (see sect
Eintrag öffnenLatuda · 4.5 · 6 Potential for lurasidone to affect other medicinal products Coadministration of lurasidone with midazolam, a
Eintrag öffnenLatuda · 4.5 · A clinical drug interaction study investigating the effect of coadministration of lurasidone on patients takin
Eintrag öffnenLatuda · 4.5 · CYP3A4 inducers Lurasidone is contraindicated with strong CYP3A4 inducers (e.g. carbamazepine, phenobarbital,
Eintrag öffnenLatuda · 4.5 · CYP3A4 inhibitors Lurasidone is contraindicated with strong CYP3A4 inhibitors (e.g. boceprevir, clarithromycin
Eintrag öffnenLatuda · 4.5 · Caution is advised when prescribing lurasidone with medicinal products known to prolong the QT interval, e.g.
Eintrag öffnenLatuda · 4.5 · Co-administration of lurasidone and posaconazole (strong CYP3A4 inhibitor) resulted in an approximate 4-5 fold
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with digoxin (a P-gp substrate) did not increase the exposure to digoxin and on
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with diltiazem (slow-release formulation), a moderate CYP3A4 inhibitor, resulte
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with lithium indicated that lithium had clinically negligible effects on the ph
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with medicinal products that moderately inhibit CYP3A4 (e.g. diltiazem, erythro
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with mild (e.g. armodafinil, amprenavir, aprepitant, prednisone, rufinamide) or
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with the strong CYP3A4 inducer rifampicin resulted in a 6-fold decrease in expo
Eintrag öffnenLatuda · 4.5 · Coadministration of lurasidone with the strong CYP3A4 inhibitor ketoconazole resulted in a 9- and 6-fold incre
Eintrag öffnenLatuda · 4.5 · Lurasidone is an in vitro inhibitor of the efflux transporter BCRP and the clinical relevance of intestinal BC
Eintrag öffnenLatuda · 4.5 · Pharmacodynamic interactions Given the primary central nervous system effects of lurasidone, lurasidone should
Eintrag öffnenLatuda · 4.5 · Pharmacokinetic interactions The concomitant administration of lurasidone and grapefruit juice has not been as
Eintrag öffnenLatuda · 4.5 · Potential for other medicinal products to affect lurasidone Lurasidone and its active metabolite ID-14283 both
Eintrag öffnenLatuda · 4.5 · Transporters Lurasidone is a substrate of P-gp and BCRP in vitro and the in vivo relevance of this is unclear.
Eintrag öffnenLatuda · 4.5 · When lurasidone is coadministered with mild or moderate CYP3A4 inducers, the efficacy of lurasidone needs to b
Eintrag öffnen